Abstract

New Perspectives on Vancomycin Use in Home Care, Part 1

Author(s): Kastango Eric S, Hadaway Lynn

Issue: Nov/Dec 2001 - High-Tech Compounding

Page(s): 465-469

Download in electronic PDF format for $75
  • New Perspectives on Vancomycin Use in Home Care, Part 1 Page 1
  • New Perspectives on Vancomycin Use in Home Care, Part 1 Page 2
  • New Perspectives on Vancomycin Use in Home Care, Part 1 Page 3
  • New Perspectives on Vancomycin Use in Home Care, Part 1 Page 4
  • New Perspectives on Vancomycin Use in Home Care, Part 1 Page 5

Abstract

With the advent of new venous access devices (VADs) and medication delivery technology, pharmacists must reconsider the historical literature and administration guidelines that pertain to vancomycin. Current literature1-3 supports the conclusion that there is no direct correlation between vancomycin concentration or rate of administration and side effects (particularly red man syndrome). Venous access devices such as midclavicular catheters, midlines, and peripheral inserted central catheters (PICCs) enable more concentrated solutions of vancomycin to be infused safely without an increased incidence of adverse events. Advances in medication delivery technology ensure the consistency of therapy protocols (including catheter flushing and administration rate) that reduce the potential for adverse events and medication errors, particularly in the unmonitored home setting.

The American Society of Health-System Pharmacists4 states that by fulfilling their responsibilities in pharmaceutical care, pharmacists have a role in meeting the primary care needs of patients. Pharmaceutical care is the direct, responsible provision of medicationrelated care to achieve an outcome that improves a patient’s quality of life. Pharmacists establish relationships with patients to ensure the appropriateness of medication therapy, to verify patients’ understanding of that therapy, and to monitor the effects of treatment. In collaborative drug therapy management, physicians and other prescribers authorize pharmacists to select appropriate medication therapies and regimens and adjust them on the basis of patients’ responses to treatment.

The delivery of pharmaceutical care requires specialized knowledge about pharmacology, vascular access devices and their placement, compounding factors (eg, osmolarity, pH, stability, particulate matter), delivery systems, and patient management. In this article, those factors will be addressed with respect to optimizing the medication delivery of and patient response to vancomycin therapy.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2002
Pg. 55-57
Nov/Dec 2001
Pg. 465-469
Jul/Aug 2015
Pg. 334-336
Sep/Oct 2020
Pg. 420-425
Jul/Aug 2011
Pg. 270-276
Author(s): Kennedy Steve
Mar/Apr 2011
Pg. 94-100
Author(s): Miron Karen E
Mar/Apr 2005
Pg. 140-144
Author(s): Fonseca Simonne C
May/Jun 2014
Pg. 190-200
May/Jun 2020
Pg. 182-186
Author(s): Riepl Mike
Jul/Aug 2020
Pg. 282-285
Author(s): Riepl Mike
Sep/Oct 1997
Pg. 294-297
Author(s): Lima Hetty A
Sep/Oct 1997
Pg. 301-305
Author(s): Lima Hetty A
May/Jun 2004
Pg. 175-178
Author(s): Biundo Bruce
Mar/Apr 1997
Pg. 123-124
May/Jun 2011
Pg. 183-188
Sep/Oct 2010
Pg. 360-364
Author(s): Canally Sandra C
Jul/Aug 2000
Pg. 246-249
Author(s): Carling Maureen A
Nov/Dec 2010
Pg. 450-455
Author(s): Franklin David M
Jan/Feb 2010
Pg. 86
Author(s): Allen Loyd V Jr
Mar/Apr 2013
Pg. 100-110